These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3037224)

  • 41. Fluorescent probes for opioid receptors.
    Kolb VM; Koman A; Terenius L
    Life Sci; 1983; 33 Suppl 1():423-6. PubMed ID: 6319896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opiate receptors in brain labelled in vivo with [3H]lofentanil.
    Laduron PM; Poncet J; Janssen PF
    Neuropharmacology; 1985 Jul; 24(7):617-20. PubMed ID: 2862603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pattern of [3H]cyclofoxy retention in rat brain after in vivo injection corresponds to the in vitro opiate receptor distribution.
    Ostrowski NL; Burke TR; Rice KC; Pert A; Pert CB
    Brain Res; 1987 Feb; 402(2):275-86. PubMed ID: 3030494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Saturable binding of dihydromorphine and naloxone to rat brain tissue in vitro.
    Lee CY; Akera T; Stolman S; Brody TM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):583-92. PubMed ID: 1159633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells.
    Rogers NF; el-Fakahany E
    Eur J Pharmacol; 1986 May; 124(3):221-30. PubMed ID: 3015639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of arachidonic acid on specific binding of [3H]naloxone to opioid receptors.
    Apaydin S; Oktem HA
    Acta Neurobiol Exp (Wars); 2000; 60(3):361-3. PubMed ID: 11016077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
    Price M; Gistrak MA; Itzhak Y; Hahn EF; Pasternak GW
    Mol Pharmacol; 1989 Jan; 35(1):67-74. PubMed ID: 2536470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opiate receptor: cooperativity of binding observed in brain slices.
    Davis ME; Akera T; Brody TM; Watson L
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5764-6. PubMed ID: 202963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system.
    Hauger RL; Hulihan-Giblin B; Skolnick P; Paul SM
    Life Sci; 1984 Feb; 34(8):771-82. PubMed ID: 6700378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of the effect of methionine enkephalin upon the stereospecific binding of an opiate agonist and an antagonist in mice and rats.
    Chau-Pham TT; Dewey WL
    Life Sci; 1977 Nov; 21(9):1337-42. PubMed ID: 200814
    [No Abstract]   [Full Text] [Related]  

  • 53. Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain.
    Rothman RB; Westfall TC
    Eur J Pharmacol; 1981 Jul; 72(4):365-8. PubMed ID: 6268425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain.
    Basile AS; Skolnick P
    J Neurochem; 1986 Jan; 46(1):305-8. PubMed ID: 2999338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states.
    Geary WA; Wooten GF
    Brain Res; 1985 Dec; 360(1-2):214-23. PubMed ID: 4075170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions.
    McCann DJ; Su TP
    Eur J Pharmacol; 1990 Apr; 188(4-5):211-8. PubMed ID: 2163873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alpha interferon interaction with opiate receptors in the rat brain].
    Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM
    Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Specific binding of 3H-naloxone with isolated rat enterocytes].
    Iarygin KN; Sviridov DD; Shitin AG; Vinogradov VA; Titov MI
    Biull Eksp Biol Med; 1985 Jul; 100(7):40-2. PubMed ID: 2990595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of opioid receptor subtypes in solution.
    Demoliou-Mason CD; Barnard EA
    J Neurochem; 1986 Apr; 46(4):1129-36. PubMed ID: 2869106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.